Piotr Dziegiel Selected Research

Metallothionein

12/2018	Expression of Metallothionein I/II and Ki-67 Antigen in Graves' Disease.
1/2017	Metallothionein Isoform Expression in Benign and Malignant Thyroid Lesions.
5/2016	Expression of Metallothionein and Vascular Endothelial Growth Factor Isoforms in Breast Cancer Cells.
2/2016	Correlation between levels of expression of minichromosome maintenance proteins, Ki-67 proliferation antigen and metallothionein I/II in laryngeal squamous cell cancer.
1/2016	Expression of SATB1, MTI/II and Ki-67 in Mycosis Fungoides.
1/2016	Metallothioneins in Normal and Cancer Cells.
1/2015	Metallothioneins in the lung cancer.
12/2013	Comparison of minichromosome maintenance proteins (MCM-3, MCM-7) and metallothioneins (MT-I/II, MT-III) expression in relation to clinicopathological data in ovarian cancer.
2/2013	Metallothionein 1F and 2A overexpression predicts poor outcome of non-small cell lung cancer patients.
12/2012	Role of metallothioneins in benign and malignant thyroid lesions.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Piotr Dziegiel Research Topics

Disease

87	Neoplasms (Cancer) 01/2022 - 03/2003
31	Breast Neoplasms (Breast Cancer) 03/2020 - 08/2004
14	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2004
13	Neoplasm Metastasis (Metastasis) 01/2020 - 03/2003
12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2009
10	Adenocarcinoma 07/2019 - 02/2004
10	Carcinoma (Carcinomatosis) 01/2017 - 03/2003
8	Carcinogenesis 01/2022 - 01/2013
8	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 09/2010
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2019 - 01/2008
4	Stomach Neoplasms (Stomach Cancer) 04/2018 - 09/2012
4	Adenoma (Adenomas) 01/2017 - 09/2009
3	Inflammation (Inflammations) 12/2018 - 09/2012
3	Nodular Goiter 12/2018 - 01/2013
3	Lymphatic Metastasis 12/2016 - 09/2011
3	Melanoma (Melanoma, Malignant) 11/2016 - 09/2009
3	Pancreatic Neoplasms (Pancreatic Cancer) 09/2016 - 01/2010
3	Ductal Carcinoma 01/2016 - 07/2008
3	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 06/2015 - 01/2013
3	Lymphoma (Lymphomas) 03/2008 - 01/2004
2	Body Weight (Weight, Body) 03/2020 - 10/2003
2	Adrenocortical Adenoma (Disease, Conn's) 03/2019 - 09/2008
2	Graves Disease (Basedow Disease) 12/2018 - 01/2013
2	Colorectal Neoplasms (Colorectal Cancer) 07/2018 - 06/2015
2	Infections 01/2018 - 05/2004
2	Papilloma (Papillomatosis) 01/2017 - 08/2016
2	Papillary Thyroid Cancer 01/2017 - 01/2016
2	Skin Diseases (Skin Disease) 01/2016 - 11/2015
2	Triple Negative Breast Neoplasms 01/2016 - 01/2015
2	Mycosis Fungoides 01/2016 - 11/2015
2	Tuberous Sclerosis (Bourneville's Disease) 06/2015 - 01/2013
2	Interstitial Lung Diseases (Interstitial Lung Disease) 06/2015 - 06/2015
2	Disease Progression 06/2015 - 02/2009
2	Actinic Keratosis 01/2013 - 10/2012
2	Basal Cell Carcinoma (Rodent Ulcer) 10/2012 - 12/2010
2	Fibrosarcoma 01/2009 - 09/2007

Drug/Important Bio-Agent (IBA)

56	Proteins (Proteins, Gene)FDA Link 06/2021 - 01/2004
27	Messenger RNA (mRNA)IBA 01/2022 - 12/2012
25	Ki-67 Antigen (Ki 67 Antigen)IBA 05/2019 - 01/2004
24	MetallothioneinIBA 12/2018 - 01/2004
13	ParaffinIBA 01/2021 - 03/2003
10	MelatoninIBA 07/2019 - 01/2002
8	Estrogen ReceptorsIBA 06/2018 - 01/2009
8	AntigensIBA 02/2016 - 01/2005
7	Protein Isoforms (Isoforms)IBA 05/2019 - 12/2012
7	Progesterone Receptors (Progesterone Receptor)IBA 06/2018 - 02/2005
5	PeriostinIBA 01/2022 - 01/2015
5	Estrogens (Estrogen)FDA Link 03/2020 - 04/2011
5	AntibodiesIBA 03/2019 - 03/2003
5	Daunorubicin (Cerubidine)FDA LinkGeneric 04/2018 - 01/2002
5	Cadherins (E-Cadherin)IBA 01/2015 - 01/2007
4	Minichromosome Maintenance ProteinsIBA 05/2019 - 12/2013
4	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2018 - 07/2003
4	Cytostatic AgentsIBA 04/2018 - 01/2002
4	CytokinesIBA 01/2018 - 06/2013
4	Glycoproteins (Glycoprotein)IBA 01/2018 - 12/2011
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2016 - 04/2011
4	Vascular Endothelial Growth Factor DIBA 12/2013 - 01/2009
3	parathymosin alphaIBA 11/2020 - 12/2012
3	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 03/2020 - 11/2015
3	Progesterone FDA LinkGeneric 03/2020 - 01/2013
3	Melatonin Receptors (Melatonin Receptor)IBA 07/2019 - 10/2009
3	Biomarkers (Surrogate Marker)IBA 05/2019 - 09/2010
3	NestinIBA 08/2018 - 08/2017
3	A-factor (Streptomyces)IBA 08/2018 - 06/2015
3	Matrix Metalloproteinases (MMPs)IBA 01/2018 - 07/2008
3	Biological ProductsIBA 10/2017 - 07/2008
3	Carrier Proteins (Binding Protein)IBA 05/2016 - 06/2015
3	lipoarabinomannan (LAM)IBA 06/2015 - 01/2013
3	Metalloproteases (Metalloproteinases)IBA 01/2015 - 07/2008
3	Vascular Endothelial Growth Factor CIBA 10/2013 - 01/2006
3	QuercetinIBA 09/2012 - 01/2010
3	AmanitinsIBA 07/2010 - 01/2009
2	ZyxinIBA 01/2022 - 11/2020
2	tesminIBA 01/2021 - 07/2019
2	Gonadal Steroid Hormones (Sex Hormones)IBA 03/2020 - 01/2017
2	Monoclonal AntibodiesIBA 02/2019 - 01/2014
2	Galactosylceramides (Galactocerebrosides)IBA 11/2018 - 01/2013
2	Mitoxantrone (Novantrone)FDA LinkGeneric 04/2018 - 09/2016
2	ResveratrolIBA 04/2018 - 09/2016
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2018 - 01/2015
2	ProlactinIBA 01/2018 - 01/2016
2	Pyruvate KinaseIBA 01/2018 - 07/2014
2	MicroRNAs (MicroRNA)IBA 01/2018 - 11/2016
2	IonsIBA 01/2017 - 05/2016
2	ZincIBA 01/2017 - 05/2016
2	MT1 Melatonin ReceptorIBA 12/2014 - 10/2009
2	Formaldehyde (Formol)FDA Link 06/2014 - 10/2009
2	Metallothionein 3IBA 12/2013 - 03/2013
2	Indicators and Reagents (Reagents)IBA 10/2013 - 09/2008
2	Tamoxifen FDA LinkGeneric 04/2013 - 08/2004
2	Ganglioside GalactosyltransferaseIBA 01/2013 - 01/2013
2	Pharmaceutical PreparationsIBA 09/2012 - 05/2008
2	Hormones (Hormone)IBA 10/2009 - 09/2009
2	beta CateninIBA 09/2007 - 01/2007

Therapy/Procedure

12	Therapeutics 01/2018 - 01/2004
7	Lasers (Laser) 01/2022 - 12/2013
7	Drug Therapy (Chemotherapy) 01/2018 - 09/2002
5	Radiotherapy 01/2015 - 05/2006
2	Transplantation 11/2018 - 01/2013